FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

420736004: Conventional release eye suspension (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2616717019 Eye suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673151016 Ophthalmic suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3620934010 Conventional release eye suspension (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3620935011 Conventional release eye suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3900391000005115 suspension til anvendelse i øjnene da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eye suspension Is a lægemiddelsuspension false Inferred relationship Some
Eye suspension Is a Ocular dose form (dose form) true Inferred relationship Some
Eye suspension Has dose form administration method (attribute) A method of administration of a dose form by placing or spreading on a body surface. true Inferred relationship Some
Eye suspension Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration to the eye or eye structures. true Inferred relationship Some
Eye suspension Has dose form release characteristic (attribute) A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties. true Inferred relationship Some
Eye suspension Has basic dose form (attribute) A liquid dose form consisting of a suspension of fine particles in a suitable vehicle. true Inferred relationship Some
Eye suspension Has dose form transformation (attribute) No transformation true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Eye drops suspension Is a False Eye suspension Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has manufactured dose form True Eye suspension Inferred relationship Some
tobramycin 0,3 % + fluorometholon 0,1 % suspension til oftalmisk anvendelse Has manufactured dose form False Eye suspension Inferred relationship Some
nepafenac 0,1 % suspension til oftalmisk anvendelse Has manufactured dose form False Eye suspension Inferred relationship Some
Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Eye suspension Inferred relationship Some
levobetaxololhydrochlorid 0,5 % suspension til oftalmisk anvendelse Has manufactured dose form False Eye suspension Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Eye suspension Inferred relationship Some
prednisolonacetat 25 mg/ml suspension Has manufactured dose form False Eye suspension Inferred relationship Some
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Eye suspension Inferred relationship Some
Prednisolone acetate 1.25 mg/mL eye suspension Has manufactured dose form True Eye suspension Inferred relationship Some
Prednisolone acetate 10 mg/mL eye suspension Has manufactured dose form True Eye suspension Inferred relationship Some
Medrysone 10 mg/mL eye suspension Has manufactured dose form True Eye suspension Inferred relationship Some
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Eye suspension Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Eye suspension Inferred relationship Some
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Eye suspension Inferred relationship Some
Loteprednol etabonate 5 mg/mL eye suspension Has manufactured dose form True Eye suspension Inferred relationship Some
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Eye suspension Inferred relationship Some
tetracyclinhydrochlorid 1 % wt/vol suspension Has manufactured dose form False Eye suspension Inferred relationship Some
Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension Has manufactured dose form True Eye suspension Inferred relationship Some
Besifloxacin 6 mg/mL eye suspension Has manufactured dose form True Eye suspension Inferred relationship Some
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Eye suspension Inferred relationship Some
Difluprednate 500 microgram/mL eye suspension Has manufactured dose form True Eye suspension Inferred relationship Some
Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Eye suspension Inferred relationship Some
Levobetaxolol 5 mg/mL eye suspension Has manufactured dose form True Eye suspension Inferred relationship Some
Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form False Eye suspension Inferred relationship Some
Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Eye suspension Inferred relationship Some

This concept is not in any reference sets

Back to Start